FDA Orders Heartburn Meds Off Shelves Over Cancer Risk
The U.S. Food and Drug Administration ordered drugmakers Wednesday to halt distribution of their versions of the heartburn medication ranitidine, more commonly known as Zantac, because of potentially carcinogenic contaminants found in the...To view the full article, register now.
Already a subscriber? Click here to view full article